healthday1h
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
ConsumerAffairs4h
FDA approves generic GLP-1 drug to treat type 2 diabetes
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
FDA approves GLP-1 generic for Type 2 diabetes
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
MedPage Today2d
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
Sierra Sun Times1d
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
Medscape2d
FDA Approves Second Generic Daily GLP-1 Drug for T2D
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
SiliconIndia2d
Biocon and Zentiva Gain EU Approval for Generic Liraglutide
Biocon and Zentiva Gain EU Approval for Generic Liraglutide - Biocon Limited , in collaboration with its European partner ...
Managed Healthcare Executive1d
FDA Approves First Once-Daily Generic of Victoza for Type 2 Diabetes
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
Biocon, Zentiva get approval for diabetes tratement drug Liraglutide for EU region
Biocon said that the company and Zentiva, its European partner, have received a de-centralized procedure (DCP) approval for its complex formulation, Liraglutide, in the European Union (EU).